Lipoprotein(a) contains one copy each of apolipoprotein B-100 and apolipoprotein(a). It has been hypothesized that a disulfide bond might exist between Cys4O" of apolipoprotein (a) Lp(a) represent an independent risk factor for the development of premature atherosclerosis (4, 5). Mice transgenic for human apo(a) develop atherosclerosis upon cholesterol feeding (6).
plasmid, almost all apolipoprotein(a) in the culture supernatant was present in lipoprotein(a)-like particles as demonstrated by immunoblotting, density-gradient centrifugation, and ELISA. The same analysis performed with supernatants of cells transfected with plasmids mutated in codon 4057 revealed free apolipoprotein(a) glycoprotein without detectable amounts of lipoprotein-associated apolipoprotein(a). Our results strongly suggest the existence of a disulfide bridge between Cys4S7 of apolipoprotein(a) and apolipoprotein B-100 within recombinant lipoprotein(a) particles. Furthermore, they indicate that disulfide bridge formation is essential for assembly of the lipoprotein(a)-like complex produced by HepG2 cells and suggest a similar role of Cys4057 during lipoprotein(a) assembly in vivo.
Lipoprotein(a) [Lp(a)] is a low density lipoprotein (LDL)-like particle composed of a cholesterol ester-rich lipid core, one molecule of apolipoprotein B-100 (apoB), and a glycoprotein called apolipoprotein(a) [apo(a)] (1). Plasma apo(a) is derived almost exclusively from the liver as shown by mRNA analysis (2) and liver transplantation studies (3) . High plasma concentrations of Lp(a) represent an independent risk factor for the development of premature atherosclerosis (4, 5) . Mice transgenic for human apo(a) develop atherosclerosis upon cholesterol feeding (6) .
Cloning and sequencing of the first complete apo(a) cDNA from human liver (7) revealed a striking homology between apo(a) and plasminogen. Both proteins belong to a protein family characterized by the presence of one or more kringle domains with six highly conserved cysteine residues, which are believed to be involved in three intradomain disulfide bridges. Plasminogen contains single copies of five different kringle domains and a serine protease domain. Referring to the numbering of plasminogen kringles, the first sequenced apo(a) cDNA encoded a glycoprotein with 37 tandemly repeated kringle IV-like domains, a single kringle V domain, and a serine protease domain. Ten distinct kringle IV domains were encoded by the sequenced apo(a) cDNA. One of them occurred in 28 identical copies; the others were unique.
In human plasma, almost all apo(a) is present as a macromolecular Lp(a) complex. As the dissociation of the LDL moiety and apo(a) in Lp(a) requires reducing conditions, a
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
disulfide bridge between apo(a) and apoB has been postulated (8, 9) . In addition to the six cysteines putatively involved in intradomain disulfide bridges, a seventh unpaired cysteine has been found in the penultimate kringle IV domains of human and rhesus monkey apo(a) (7, 10) . It has been hypothesized that this cysteine occurring in codon 4057 (kringle 36) might be involved in disulfide linkage to apoB (7) .
To directly address the role of Cys4057 for the assembly of Lp(a) we have used the human hepatocarcinoma cell line HepG2. These cells, although capable of secreting different apoB-containing lipoprotein particles (11, 12) code eight kringle 2A repeats. The unique 3' sequences ofthe apo(a) cDNA, encoding kringles 30-37 and kringle V, were obtained from human liver poly(A)+ RNA by reverse transcription/PCRs. Five overlapping fragments were PCR amplified from the first-strand cDNA product and successively aligned by further PCRs and subcloning steps. DNA prepared from a human liver cDNA library (Clontech) was used as a template to amplify a 700-bp fragment encoding the apo(a) protease domain and 50 bp of 3' untranslated apo(a) sequences. A detailed description of the pCMV-A18 construction is available on request.
Site-Directed PCR Mutagenesis. To introduce single point mutations inito the plasmid pCMV-A18, a 1.1-kb Aat II/Msc I fragment was replaced with fragments containing the desired nucleotide exchanges. The mutagenized fragments were prepared by two rounds of PCR (Fig. 1 ). Oligonucleotides 1 (GATCGAATTCGTGTCCTTGCGACGT), 2A (CCTCACAGACGGATCGGTTG), 3A (CCGATCCGTCT-GTGAGGTGG), 2B (CCTCACACCCGGATCGGTTG), 3B (CCGATCCGGGTGTGAGGTGG), and 4 (GATCGTCGAC-TGGCCATTACCATGA) were used to amplify two overlapping fragments for each mutation. Subsequent alignment of the overlapping PCR fragments was achieved by second rounds of PCR with external primers 1 and 4. The identity of the desired mutations as well as the correctness of all PCR-derived sequences were verified by DNA sequence analysis.
DNA Sequence Analysis. Double-stranded plasmid DNAs were sequenced (17) (20) . Immunodetections using apo(a)-specific antibody 1A2 (21) or a rabbit antiserum raised against human LDL were performed with the ECL Western blot detection kit (Amersham).
Ultracentrifugation. Culture supernatants (2 ml) were adjusted to a density of 1.21 g/ml with potassium bromide (KBr) and centrifuged 90 min at 85,000 rpm and 10°C in a Beckmann TL-100 centrifuge equipped with a TLV-100 rotor. The top 500 ,ul was collected as lipoprotein fraction. Density-gradient centrifugation was performed as described (22) . Tubes were unloaded from the bottom into 22 (Fig. 2,  lane 2) . The observed electrophoretic mobility of pCMV-A18-encoded apo(a) indicates extensive posttranslational modification of HepG2-derived r-apo(a) as described for human plasma apo(a) (23) and for r-apo(a) derived from transfection of a similar construct in HepG2 and 293 cells (24) . The broad r-apo(a) bands in Fig. 2 result from loading the corresponding lanes. With less protein loaded to the gel, the r-apo(a) bands become much sharper and migrate to a position between isoforms Si and S2 (data not shown).
To investigate how much of the pCMV-A18-encoded apo(a) expressed in HepG2 cells was associated with lipoproteins, culture medium conditioned by transfected cells was fractionated by ultracentrifugation. Equivalent aliquots of unfractionated culture medium and lipoprotein fraction were analyzed by immunoblotting. As shown in Fig. 2 (lanes  2 and 3) , there was almost no difference in the intensity of anti-apo(a)-reactive protein in both samples, indicating that the majority of r-apo(a) produced by pCMV-A18-transfected HepG2 cells was present in the lipoprotein fraction.
Lp(a) Particle Assembly Is Affected by Mutations of Cys4"7.
By means of site-directed mutagenesis we exchanged the TGT codon encoding Cys4057 in pCMV-A18 to either TCT (serine) or GGT (glycine). The resulting mutant plasmids were designated pCMV-A18-4057Ser and pCMV-A18-4057GIY, respectively.
Wild-type and mutant apo(a) plasmids were transiently expressed in HepG2 cells. Forty-eight hours after transfection, apo(a) entities in the culture medium were characterized by three methods: (i) SDS/PAGE performed under reducing and nonreducing conditions was combined with immunoblotting using antibodies specific for either apo(a) or apoB. The results are shown in Fig. 3 . Under reducing conditions (Fig.  3A) , wild-type and mutant r-apo(a) migrated to the same position corresponding to an apparent molecular mass of 550 kDa. When analyzed under nonreducing conditions, wildtype r-apo(a) exists almost exclusively as a high molecular weight complex with apoB. In contrast, both mutant r-apo(a) migrated as uncomplexed glycoproteins.
(ii) To analyze whether the mutant r-apo(a) associate with apoB under nondenaturing conditions, culture supernatants of transfected HepG2 cells expressing either wild-type or mutant or truncated apo(a) were fractionated by KBr densitygradient centrifugation. A truncated apo(a) variant lacking the C-terminal kringles 32 to kringle V and the protease domain was obtained by transfection of plasmid pCMV-A18 A5-P in which the corresponding cDNA sequences have been substituted by a stop codon. Gradient fractions were analyzed with respect to their apo(a) and apoB contents by ELISA. Wild-type r-apo(a) produced by HepG2 cells was found predominantly in lipoprotein particles with a density between LDL and HDL (high density lipoprotein), as described for Lp(a) particles in human plasma (Fig. 4A) . Both mutant r-apo(a) as well as the truncated apo(a) variant occur predominantly as free glycoproteins in the bottom fractions of the gradients (Fig. 4 B-D) .
(ii) High-salt conditions during density-gradient centrifugation might prevent the detection of low-affinity interactions between mutant r-apo(a) and apoB-containing lipoproteins. Therefore, we combined apo(a)-and apoB-specific reagents in sandwich ELISAs to study the interaction of r-apo(a) with apoB-containing lipoproteins under physiological salt conditions. Again, apo(a)-apoB complexes were identified only in the supernatant of HepG2 cells transfected with wild-type apo(a) plasmid (Table 1) . No such complexes could be detected for either of the mutant apo(a) proteins.
DISCUSSION
In the present study, we have tested whether Cys57i required for Lp(a) particle assembly by expressing wild-type r-apo(a) and two different mutants thereof in HepG2 cells. The mutants have either a Cys --+ Ser or a Cys -+) Gly substitution at position 4057. Neither substitution should interfere with the folding of the penultimate kringle IV domain of apo(a) because serine and glycine are present in most other kringle IV domains of apo(a) at the position homologous to Cys4057 (7) . The presence of Lp(a)-like particles in the media from cells transfected with wild-type apo(a) plasmid was demonstrated by three methods. The same methods did not reveal Lp(a) particle formation for either of the two mutants. This was not due to reduced expression of apo(a) or apoB, because cells transfected with either wildtype or mutant apo(a) plasmids expressed comparable amounts of both apo(a) and apoB as shown in several independent experiments ( selective fluorescence labeling experiments and molecular modeling studies, which suggest a single disulfide bridge between apo(a) and apoB (25, 26) with Cys3734 of apoB covalently linked to apo(a) within the Lp(a) complex (26, 27) .
Beyond the corroboration of the disulfide hypothesis, our data strongly suggest an essential role of Cys4057 for assembly of Lp(a) particles. In the HepG2 system, we were unable to detect any Lp(a)-like particles in the absence of Cys4057 even under physiological salt conditions. We cannot exclude the involvement of other, noncovalent interactions in the Lp(a) assembly. On the contrary, it is difficult to imagine that two of the largest proteins should interact exclusively by a single disulfide bridge. Molecular modeling and docking experiments with models of apo(a) kringle 36 and energy-miinimized segments of apoB suggest complex interactions between the penultimate kringle IV repeat of apo(a) and the putatively surface-exposed segment 3732-3739 of apoB including multiple van der Waals contacts (26) . Interactions between other apo(a) kringle domains and apoB might also contribute to the Lp(a) assembly. Recently, reconstitution experiments with apo(a) transgenic plasma and purified human LDL demonstrated rapid SDS-resistant association between r-apo(a) and LDL particles, which could be dissociated only by reductive treatment (28) . A study with long-term cultured primary baboon hepatocytes also suggests that apo(a) and apoB can become disulfide bridged outside the cell (29) . The inhibition of this association in the presence of the lysine analog e-aminocaproic acid (EACA) suggests that interactions between lysine residues of apoB and lysine-binding apo(a) kringle domains might play an important role during Lp(a) assembly. In vitro association experiments with 293 cellderived r-apo(a) and human plasma LDL (30) add further support to this hypothesis. In these experiments, noncovalent, EACA-sensitive interactions between purified r-apo(a) and LDL were demonstrated by sedimentation analysis.
Based on our finding of the essential role of Cys4057 for Lp(a) assembly and the data mentioned above on the interference of EACA with this process, we propose a two-step model for Lp(a) assembly as shown in Fig. 5 . According to this model, multiple noncovalent interactions, including interactions between lysine-binding kringles of apo(a) and lysine residues in apoB, serve to position Cys457 of apo(a) close to Cys3734 of apoB in the first step. This EACAsensitive step might be followed by formation of the interchain disulfide bridge in the second step.
The experiments described here emphasize the importance of the disulfide bridge between apoB and apo(a) but do not provide a clue to the site of Lp(a) assembly. In eukaryotic cells, intra-and interchain disulfide bridging of newly synthesized secretory proteins usually occurs under the oxidizing conditions within the endoplasmic reticulum (ER). The ER resident enzyme protein disulfide isomerase (PDI) plays an important role in disulfide bridge formation of many proteins (31) . The rapid covalent association of r-apo(a) and human LDL in the plasma of apo(a) transgenic mice (28) indicates that PDI is not required for extracellular Lp(a) assembly. Whether in vivo Lp(a) assembly occurs in the hepatocyte and/or in the plasma remains to be resolved. The recombinant HepG2 model described here represents a useful tool to study the biosynthesis of Lp(a) in an in vitro system. Stable variants of this model can now be used to identify inhibitors of Lp(a) biosynthesis. As plasma levels of Lp(a) are controlled by the apo(a) gene and regulated at the biosynthetic level (32) (33) (34) , such compounds might be developed to a new class of antiatherosclerotic drugs that reduce the increased risk of premature atherosclerosis associated with high plasma Lp(a) levels.
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